Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Diabetes Care 29:1599-1604, 2006
DOI: 10.2337/dc06-0581
© 2006 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bacha, F.
Right arrow Articles by Arslanian, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bacha, F.
Right arrow Articles by Arslanian, S. A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Cardiovascular and Metabolic Risk
Original Article

Are Obesity-Related Metabolic Risk Factors Modulated by the Degree of Insulin Resistance in Adolescents?

Fida Bacha, MD, Rola Saad, MD, Neslihan Gungor, MD and Silva A. Arslanian, MD

Division of Pediatric Endocrinology, Metabolism and Diabetes Mellitus and the Weight Management and Wellness Center, Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania

Address correspondence and reprint requests to Silva A. Arslanian, MD, Weight Management and Wellness Center, Children’s Hospital of Pittsburgh, 3705 Fifth Ave. at DeSoto St., Pittsburgh, PA 15213. E-mail: silva.arslanian{at}chp.edu

OBJECTIVE—Obesity is often associated with insulin resistance and the components of the metabolic syndrome. However, wide variations in insulin sensitivity are noted in obese youth. It is not clear if greater insulin resistance confers a higher risk of cardiovascular comorbidities and risk for type 2 diabetes.

RESEARCH DESIGN AND METHODS—We investigated physical and metabolic features of 54 obese adolescents. Subsequently, we pair matched 17 moderately insulin-resistant (MIR group) to 17 severely insulin-resistant (SIR group) youth based on cut points for insulin sensitivity (MIR group insulin sensitivity within 2 SDs and SIR group <2 SDs of normal-weight adolescent values). We evaluated differences in body composition (dual-energy X-ray absorptiometry), abdominal fat (computed tomography scan), cardiorespiratory fitness (CRF) (VO2max on a treadmill), insulin sensitivity and secretion (hyperinsulinemic-euglycemic and hyperglycemic clamps), substrate utilization (indirect calorimetry), and fasting adiponectin and lipid profile.

RESULTS—SIR youth had higher visceral adiposity (78.3 ± 6.9 vs. 60.3 ± 6.9 cm2, P = 0.017) and waist-to-hip ratio (0.91 ± 0.01 vs. 0.86 ± 0.02, P = 0.026) and lower HDL (1.0 ± 0.03 vs. 1.16 ± 0.06 mmol/l, P = 0.015) than pair-matched MIR subjects. There was a tendency for adiponectin (6.1 ± 0.5 vs. 8.6 ± 1.1 µg/ml, P = 0.079) and CRF (49.9 ± 3.2 vs. 55.2 ± 3.5 ml · min–1 · kg–1 fat-free mass, P = 0.09) to be lower in SIR subjects. SIR youth also had an impaired balance between insulin sensitivity and ß-cell compensation with a lower glucose disposition index.

CONCLUSIONS—Despite similar BMI, the degree of insulin resistance impacts the risk for obesity-related metabolic comorbidities. The SIR youth are at greater risk for type 2 diabetes and cardiovascular disease.

Abbreviations: CRF, cardiorespiratory fitness • CVD, cardiovascular disease • FFM, fat-free mass • VAT, visceral adipose tissue


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
C. Le Stunff, A. Dechartres, E. Miraglia Del Giudice, P. Froguel, and P. Bougneres
A Single-Nucleotide Polymorphism in the p110 Gene Promoter Is Associated with Partial Protection from Insulin Resistance in Severely Obese Adolescents
J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 212 - 215.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
T. Sturmer, J. E. Buring, I-M. Lee, J. M. Gaziano, and R. J. Glynn
Metabolic Abnormalities and Risk for Colorectal Cancer in the Physicians' Health Study
Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2391 - 2397.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2006 by the American Diabetes Association.